LEAP THERAPEUTICS INC (LPTX) Stock Cash Flow
NASDAQ:LPTX - Nasdaq - US52187K2006 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -69.17M | -67.56M | -81.41M | -54.60M | -40.59M | |||
| Depreciation Amortization | 0.00 | 5.00K | 15.00K | 16.00K | 29.00K | |||
| Income Taxes - Deferred | N/A | N/A | N/A | 152.00K | 11.00K | |||
| Change In Working Capital | 3.99M | 1.29M | 2.51M | -803.00K | 1.00M | |||
| Other non cash items | 5.92M | 5.96M | 35.13M | 6.19M | 4.39M | |||
| OPERATING CASH FLOW | -59.26M | -60.30M | -43.75M | -49.04M | -35.16M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Investing Activity | N/A | N/A | 48.97M | N/A | 0.00 | |||
| INVESTING CASH FLOW | N/A | N/A | 48.97M | N/A | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 120.00K | 133.00K | -29.00K | 0.00 | 98.22M | |||
| Other Financing Activity | N/A | 37.05M | -1.00K | -210.00K | -184.00K | |||
| FINANCING CASH FLOW | 37.09M | 37.18M | -30.00K | -210.00K | 98.03M | |||
| Exchange Rate Effect | -39.00K | -279.00K | -43.00K | -162.00K | -33.00K | |||
| CHANGE IN CASH | -22.21M | -23.39M | 5.14M | -49.42M | 62.84M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -59.26M | -60.30M | -43.75M | -49.04M | -35.16M | |||
| Capital Expenditure | N/A | N/A | N/A | N/A | 0.00 | |||
| FREE CASH FLOW | -59.26M | -60.30M | -43.75M | -49.04M | -35.16M | |||
All data in USD